Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) News
Latest headlines that mention AMRX, newest first · each headline opens the original publisher
- Last price
- $19.65
- Day change
- +0.00%
- Next earnings
- 2026-10-29
AMRX headlines
latest coverageRevenue hit $796 million as biosimilar strategy accelerates with Kashiv acquisition.
Revenue hit $796 million as biosimilar strategy accelerates with Kashiv acquisition.
Also mentioned with AMRX
30dHeadlines that tag both tickers
AMRX news alerts
Get an alert by email or push when a new headline mentions AMRX.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.